Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arpit Dheeraj

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Chemmedchem|May 14, 2025
Designing Cyclic Nitrogen-Bridged Sulfonamides with Anti-Cancer ActivityBenedikt W Grau, Arpit Dheeraj, Irimpan I Mathews, et al.
Hypoxia (Auckland, N.Z.)|September 4, 2018
A novel approach to target hypoxic cancer cells via combining β-oxidation inhibitor etomoxir with radiationArpit Dheeraj, Chapla Agarwal, Isabel R Schlaepfer, et al.
Photochemistry and Photobiology|January 26, 2017
Silibinin Treatment Inhibits the Growth of Hedgehog Inhibitor-Resistant Basal Cell Carcinoma Cells via Targeting EGFR-MAPK-Akt and Hedgehog SignalingArpit Dheeraj, Cynthia M Rigby, Cindy L O'Bryant, et al.
The Prostate|January 4, 2023
Decursin inhibits EGFR-ERK1/2 signaling axis in advanced human prostate carcinoma cellsTariq A Bhat, Arpit Dheeraj, Dhanya K Nambiar, et al.
ACS Omega|September 2, 2025
Novel Aza-podophyllotoxin Derivative Inhibits Growth of Triple-Negative Breast CancerArpit Dheeraj, Fernando Jose Garcia Marques, Blake Chennai, et al.
Cell Reports. Medicine|August 24, 2024
Uncovering therapeutic targets for macrophage-mediated T cell suppression and PD-L1 therapy sensitizationSushil Kumar, Dhanir Tailor, Arpit Dheeraj, et al.
Cell Reports. Medicine|November 8, 2025
Non-orthosteric inhibition of enolase 1 impedes growth of triple-negative breast cancerDhanir Tailor, Fernando Jose Garcia-Marques, Abel Bermudez, et al.
European Journal of Medicinal Chemistry|May 30, 2026
Development of indole derived non-orthosteric inhibitors for Proto-oncogene serine/threonine-protein kinase PIM-1Benedikt W Grau, Dhanir Tailor, Mallesh Pandrala, et al.
Molecular Cancer Therapeutics|April 29, 2026
YB-1 inhibition suppresses osteosarcoma growth and reverses tumor immunosuppressionSanjay V Malhotra, Kirsten Stefan, Jee Min Lee, et al.
Cell Reports. Medicine|May 10, 2024
Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategyArpit Dheeraj, Fernando Jose Garcia Marques, Dhanir Tailor, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Chemmedchem|May 14, 2025
Designing Cyclic Nitrogen-Bridged Sulfonamides with Anti-Cancer ActivityBenedikt W Grau, Arpit Dheeraj, Irimpan I Mathews, et al.
Hypoxia (Auckland, N.Z.)|September 4, 2018
A novel approach to target hypoxic cancer cells via combining β-oxidation inhibitor etomoxir with radiationArpit Dheeraj, Chapla Agarwal, Isabel R Schlaepfer, et al.
Photochemistry and Photobiology|January 26, 2017
Silibinin Treatment Inhibits the Growth of Hedgehog Inhibitor-Resistant Basal Cell Carcinoma Cells via Targeting EGFR-MAPK-Akt and Hedgehog SignalingArpit Dheeraj, Cynthia M Rigby, Cindy L O'Bryant, et al.
The Prostate|January 4, 2023
Decursin inhibits EGFR-ERK1/2 signaling axis in advanced human prostate carcinoma cellsTariq A Bhat, Arpit Dheeraj, Dhanya K Nambiar, et al.
ACS Omega|September 2, 2025
Novel Aza-podophyllotoxin Derivative Inhibits Growth of Triple-Negative Breast CancerArpit Dheeraj, Fernando Jose Garcia Marques, Blake Chennai, et al.
Cell Reports. Medicine|August 24, 2024
Uncovering therapeutic targets for macrophage-mediated T cell suppression and PD-L1 therapy sensitizationSushil Kumar, Dhanir Tailor, Arpit Dheeraj, et al.
Cell Reports. Medicine|November 8, 2025
Non-orthosteric inhibition of enolase 1 impedes growth of triple-negative breast cancerDhanir Tailor, Fernando Jose Garcia-Marques, Abel Bermudez, et al.
European Journal of Medicinal Chemistry|May 30, 2026
Development of indole derived non-orthosteric inhibitors for Proto-oncogene serine/threonine-protein kinase PIM-1Benedikt W Grau, Dhanir Tailor, Mallesh Pandrala, et al.
Molecular Cancer Therapeutics|April 29, 2026
YB-1 inhibition suppresses osteosarcoma growth and reverses tumor immunosuppressionSanjay V Malhotra, Kirsten Stefan, Jee Min Lee, et al.
Cell Reports. Medicine|May 10, 2024
Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategyArpit Dheeraj, Fernando Jose Garcia Marques, Dhanir Tailor, et al.
Pageof 2